201 related articles for article (PubMed ID: 25804872)
1. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.
Ernsting MJ; Hoang B; Lohse I; Undzys E; Cao P; Do T; Gill B; Pintilie M; Hedley D; Li SD
J Control Release; 2015 May; 206():122-30. PubMed ID: 25804872
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cells.
Tran TH; Ramasamy T; Choi JY; Nguyen HT; Pham TT; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Int J Nanomedicine; 2015; 10():5249-62. PubMed ID: 26346426
[TBL] [Abstract][Full Text] [Related]
3. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
[TBL] [Abstract][Full Text] [Related]
4. Species-Deconvolved Proteomics for
Wang X; Niu J; Qian S; Shen S; Straubinger RM; Qu J
J Proteome Res; 2023 Jul; 22(7):2436-2449. PubMed ID: 37311110
[TBL] [Abstract][Full Text] [Related]
5. Engineered nanomicelles targeting proliferation and angiogenesis inhibit tumour progression by impairing the synthesis of ceramide-1-phosphate.
Yadav P; Rana K; Chakraborty R; Khan A; Mehta D; Jain D; Aggarwal B; Jha SK; Dasgupta U; Bajaj A
Nanoscale; 2024 May; 16(21):10350-10365. PubMed ID: 38739006
[TBL] [Abstract][Full Text] [Related]
6. Metastatic progression is associated with dynamic changes in the local microenvironment.
Aiello NM; Bajor DL; Norgard RJ; Sahmoud A; Bhagwat N; Pham MN; Cornish TC; Iacobuzio-Donahue CA; Vonderheide RH; Stanger BZ
Nat Commun; 2016 Sep; 7():12819. PubMed ID: 27628423
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy.
Mooney R; Weng Y; Garcia E; Bhojane S; Smith-Powell L; Kim SU; Annala AJ; Aboody KS; Berlin JM
J Control Release; 2014 Oct; 191():82-9. PubMed ID: 24952368
[TBL] [Abstract][Full Text] [Related]
8. Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
Griffin JI; Chen X; Duan L; Mu Q; Ho RJY
PLoS One; 2024; 19(3):e0300723. PubMed ID: 38547077
[TBL] [Abstract][Full Text] [Related]
9. Utilizing G2/M retention effect to enhance tumor accumulation of active targeting nanoparticles.
Hu G; Cun X; Ruan S; Shi K; Wang Y; Kuang Q; Hu C; Xiao W; He Q; Gao H
Sci Rep; 2016 Jun; 6():27669. PubMed ID: 27273770
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models.
Karimnia V; Stanley ME; Fitzgerald CT; Rizvi I; Slack FJ; Celli JP
Photochem Photobiol; 2023 Jan; 99(1):120-131. PubMed ID: 35699307
[TBL] [Abstract][Full Text] [Related]
11. Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer.
Etman SM; Mehanna RA; Bary AA; Elnaggar YSR; Abdallah OY
Int J Biol Macromol; 2021 Feb; 170():284-297. PubMed ID: 33340624
[TBL] [Abstract][Full Text] [Related]
12. Breaking the stromal barrier in pancreatic cancer: Advances and challenges.
Chakkera M; Foote JB; Farran B; Nagaraju GP
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189065. PubMed ID: 38160899
[TBL] [Abstract][Full Text] [Related]
13. Carrier-Free Nanoassembly of Curcumin-Erlotinib Conjugate for Cancer Targeted Therapy.
Cheng C; Sui B; Wang M; Hu X; Shi S; Xu P
Adv Healthc Mater; 2020 Oct; 9(19):e2001128. PubMed ID: 32893507
[TBL] [Abstract][Full Text] [Related]
14. Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression.
Zabransky DJ; Chhabra Y; Fane ME; Kartalia E; Leatherman JM; Hüser L; Zimmerman JW; Delitto D; Han S; Armstrong TD; Charmsaz S; Guinn S; Pramod S; Thompson ED; Hughes SJ; O'Connell J; Egan JM; Jaffee EM; Weeraratna AT
Cancer Res; 2024 Apr; 84(8):1221-1236. PubMed ID: 38330147
[TBL] [Abstract][Full Text] [Related]
15. Dual Enzyme Cascade-Activated Popcorn-Like Nanoparticles Efficiently Remodeled Stellate Cells to Alleviate Pancreatic Desmoplasia.
Cao J; Wu J; Yang P; Qian K; Cheng Y; Xu M; Sheng D; Meng R; Wang T; Li Y; Wei Y; Zhang Q
ACS Nano; 2023 Oct; 17(20):19793-19809. PubMed ID: 37805928
[TBL] [Abstract][Full Text] [Related]
16. Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications.
Kong X; Li L; Li Z; Xie K
Cytokine Growth Factor Rev; 2012 Dec; 23(6):343-56. PubMed ID: 22749856
[TBL] [Abstract][Full Text] [Related]
17. Engineered nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression.
Yadav P; Rana K; Nardini V; Khan A; Pani T; Kar A; Jain D; Chakraborty R; Singh R; Jha SK; Mehta D; Sharma H; Sharma RD; Deo SVS; Sengupta S; Patil VS; Faccioli LH; Dasgupta U; Bajaj A
J Control Release; 2024 Apr; 368():548-565. PubMed ID: 38462044
[TBL] [Abstract][Full Text] [Related]
18. High-precision targeting and destruction of cancer-associated PDGFR-β
Voltà-Durán E; Alba-Castellón L; Serna N; Casanova I; López-Laguna H; Gallardo A; Sánchez-Chardi A; Villaverde A; Unzueta U; Vázquez E; Mangues R
Acta Biomater; 2023 Oct; 170():543-555. PubMed ID: 37683965
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cell membrane-derived nanoparticles as therapeutic carriers for pancreatic ductal adenocarcinoma using an in vitro tumour stroma model.
Tapeinos C; Torrieri G; Wang S; Martins JP; Santos HA
J Control Release; 2023 Oct; 362():225-242. PubMed ID: 37625597
[TBL] [Abstract][Full Text] [Related]
20. Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer.
Sunami Y; Böker V; Kleeff J
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
